Australia's Nyrada hits over 2-1/2-mth high after drug tieup extension

Nyrada

18/01/2023 03:05

** Shares of Australia's Nyrada Inc  NYR.AX  rise as much as
10% to A$0.165, hitting their highest since Oct.26, 2022
    ** Stock set to mark best day since Jan.6, if gains hold 
    ** Drug developer says collaboration with the Walter Reed
Army Institute of Research and UNSW Sydney has been extended
until Jan 2025
    ** Says, under collaboration, scientific teams will evaluate
the efficacy of co’s brain injury drug candidate to reduce
secondary damage following a traumatic head injury
    ** Stock has risen 3.5% this year, as of last close
 (Reporting by Nausheen Thusoo in Bengaluru)
 ((Nausheen.Thusoo@thomsonreuters.com;))